Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of mixed HEXA/PENTA/HEXA primary vaccination schedule with V419 (PR5I) and Pediacel
2012-004221-25Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of haemophilus influenzae type b vaccine in hepatitis B (HBV), diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by Sanofi. Started Jan 2013; status: completed.
02
Drugs
haemophilus influenzae type b vaccine
03
Conditions
hepatitis B (HBV)diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on 2012-004221-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004221-25.